Summary

Results presented at oncology conference in Chicago show Galleri test failed to reduce late-stage cancer diagnoses A blood test for more than 50 types of cancer that was billed as the holy grail of oncology has failed to achieve its main objective in a major clinical trial, according to data presented at the world’s largest cancer conference.

AI summaries can be wrong sometimes—always verify important details using the source article.